Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05303987 · ClinicalTrials.gov registry record · Phase 2
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
A Phase 2 study of Obstructive Sleep Apnea, sponsored by Erin Kirkham.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05303987 is a Phase 2 study of Obstructive Sleep Apnea that is actively recruiting participants, run by Erin Kirkham. The registered enrollment target is 90 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05303987, a Phase 2 study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Erin Kirkham.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is designed to learn, first, whether two anesthetics have different effects on collapse seen within the upper airway during sleep endoscopy. A second purpose is to learn whether collapse at several levels of the upper airway is associated with obstructive sleep apnea that persists after adenotonsillectomy, the surgery that removes the tonsils and adenoids.
Conditions Studied
Interventions
- DRUG Propofol sedation
- DRUG Dexmedetomidine sedation
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2026-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05303987
The ClinicalTrials.gov registry entry for NCT05303987 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (59% lower). The listed sponsor is Erin Kirkham, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Propofol sedation is the first listed.
NCT05303987 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05303987 about?
NCT05303987 is a clinical study titled "Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea". This research study is designed to learn, first, whether two anesthetics have different effects on collapse seen within the upper airway during sleep endoscopy. A second purpose is to learn whether collapse at several levels of the upper airway is associated with obstructive sleep apnea that persist...
What is the current status of trial NCT05303987?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2022-10-05. Estimated completion is 2026-08-31.
What conditions does trial NCT05303987 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT05303987?
The interventions under investigation include: Propofol sedation (DRUG), Dexmedetomidine sedation (DRUG).
Who is sponsoring clinical trial NCT05303987?
This trial is sponsored by Erin Kirkham, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05303987 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
RECRUITING · Phase 2
-
Down Syndrome Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Endotypic Traits and Obstructive Sleep Apnea Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.